Methotrexate-based PROTACs as DHFR-specific chemical probes
Cell Chemical Biology · 2024
DOI: 10.1016/j.chembiol.2023.09.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Chemical Biology, 2024. Verfasst von Sandeep Rana und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, MD 20850, USA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Folic Acid Antagonists, Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NCI NIH HHS, Intramural NIH HHS.
Abstract (Originalsprache)
Methotrexate (MTX) is a tight-binding dihydrofolate reductase (DHFR) inhibitor, used as both an antineoplastic and immunosuppressant therapeutic. MTX, like folate undergoes folylpolyglutamate synthetase-mediated γ-glutamylation, which affects cellular retention and target specificity. Mechanisms of MTX resistance in cancers include a decrease in MTX poly-γ-glutamylation and an upregulation of DHFR. Here, we report a series of potent MTX-based proteolysis targeting chimeras (PROTACs) to investigate DHFR degradation pharmacology and one-carbon biochemistry. These on-target, cell-active PROTACs show proteasome- and E3 ligase-dependent activity, and selective degradation of DHFR in multiple cancer cell lines. By comparison, treatment with MTX increases cellular DHFR protein expression. Importantly, these PROTACs produced distinct, less-lethal phenotypes compared to MTX. The chemical probe set described here should complement conventional DHFR inhibitors and serve as useful tools for studying one-carbon biochemistry and dissecting complex polypharmacology of MTX and related drugs. Such compounds may also serve as leads for potential autoimmune and antineoplastic therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, MD 20850, USA.
- Center for Cancer Research, National Cancer Institute, NIH, Frederick, MD, USA.
- Department of Oncology Science, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA.
- Department of Oncology Science, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA; OU Health Stephenson Center, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA.
- Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, MD 20850, USA. Electronic address: bantukallug@mail.nih.gov.
- Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, MD 20850, USA; Metabolic Medicine Branch, National Human Genome Research Institute, NIH, Bethesda, MD 20892, USA.…
Förderung
- NCATS NIH HHS
- NCI NIH HHS
- Intramural NIH HHS
- National Institutes of Health
- U.S. Department of Health and Human Services
- National Center for Advancing Translational Sciences
- National Cancer Institute
Zitieren
APA
Rana, S., Dranchak, P., Dahlin, J. L., Lamy, L., Li, W., Oliphant, E., Shrimp, J. H., Rajacharya, G. H., Tharakan, R., Holland, D. O., Whitten, A. S., Wilson, K. M., Singh, P. K., Durum, S. K., Tao, D., Rai, G., & Inglese, J. (2024). Methotrexate-based PROTACs as DHFR-specific chemical probes. Cell Chemical Biology. https://doi.org/10.1016/j.chembiol.2023.09.014
Vancouver
Rana S, Dranchak P, Dahlin JL, Lamy L, Li W, Oliphant E, et al. Methotrexate-based PROTACs as DHFR-specific chemical probes. Cell Chemical Biology. 2024. doi:10.1016/j.chembiol.2023.09.014
BibTeX
@article{Rana2024,
author = {Rana, Sandeep and Dranchak, Patricia and Dahlin, Jayme L and Lamy, Laurence and Li, Wenqing and Oliphant, Erin and Shrimp, Jonathan H and Rajacharya, Girish H and Tharakan, Ravi and Holland, David O and Whitten, Apryl S and Wilson, Kelli M and Singh, Pankaj K and Durum, Scott K and Tao, Dingyin and Rai, Ganesha and Inglese, James},
title = {Methotrexate-based PROTACs as DHFR-specific chemical probes},
journal = {Cell Chemical Biology},
year = {2024},
doi = {10.1016/j.chembiol.2023.09.014}
}
EUVIMED